Navigation Links
Pharmac to Phase Out Aropax, Well-known Antidepressant

Government Drug Agency, Pharmac, is in the process of doing away with a commonly used antidepressant, Aropax. //

Pharmac intends to phase out the ‘Aropax’ brand of paroxetine and bring in the generic alternative ‘Loxamine’. It is estimated that Aropax is used by about 49,000 New Zealanders.

This move has drawn flak from psychiatrists in Australasia. Yet, the agency maintains that both drugs are the same, except for the appearance and the packaging. Further, this move is expected to result in a saving of $45 million over a three year period.

Dr Allen Fraser, chairman of the New Zealand national committee of the Royal Australian and New Zealand College of Psychiatrists, said, "What concerns the college is the insistence in this process that patients currently on paroxetine, the Aropax form, must either pay for it, or be changed to the new form. We had advocated that where the clinician prescribing the medication believed it was in the patient's interest to remain on their current medication, it should remain fully subsidized for those persons. They clearly have not accepted that as a standard. We will still be pursuing that because that's the major issue for us. If patients have been doing well on their current medication, they deserve to still have access to it.”

Pharmac deputy medical director Dr Dilky Rasiah said, "At present, people prescribed paroxetine for the first time need to have previously had a trial of fluoxetine, another antidepressant. Once Loxamine is funded, it will not be subject to this requirement, which will give people easier access to it."

Dr Rasiah said that tests have confirmed the effectiveness of Loxamine brand, at par with Aropax , so patients will not experience any difficulties with change in drug.



'"/>




Page: 1

Related medicine news :

1. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Medicis Pharmaceutical company enters pediatric market
4. Pharmacies in for a dose of bitter medicine
5. Pharmacia may take 51.5 percent Abbott stake
6. Pharmaceutical companies are targeting patients
7. FDA approves Watson Pharmaceuticals Oxytrol patch
8. Pharmacist’s Role in Medication Error
9. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
10. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
11. Pharmaceutical industries grant for R&D to be monitored
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... ... care professionals, today announced that it has raised $1.675 M in seed funding ... Rethink Education, Lumina Foundation, and Techstars Venture Capital Fund are the company’s primary ...
(Date:8/17/2017)... Ca (PRWEB) , ... August 17, 2017 , ... Centrifugation ... useful tools in the laboratory that we can no longer do without. And just ... the lifetime of your device. , In this webinar, attendees will learn about the ...
(Date:8/16/2017)... , ... August 16, 2017 , ... The next Patient ... being accepted. , Students who successfully complete the seven-week long Patient Care Academy ... Assistant (CNA). The average starting salary for a CNA in Kalamazoo is $24,428.* , ...
(Date:8/16/2017)... ... August 16, 2017 , ... The Data Council, ... that it was acquired by Advantage Solutions. The Data Council’s IX-ONE platform ... include the industry’s leading suppliers, brokers, distributors and retailers. The Data Council will ...
(Date:8/16/2017)... ... August 16, 2017 , ... QualDerm Partners , a ... today announced Cumberland Skin Surgery and Dermatology has joined the company ... in both Hermitage and Lebanon, Tennessee, provides comprehensive general dermatology and skin cancer ...
Breaking Medicine News(10 mins):
(Date:8/10/2017)...  Physical Rehabilitation Network (PRN), acquired the long-standing outpatient rehabilitation ... . The reputable clinic will continue to be co-owned ... his staff of four clinicians. Lipkin received his doctorate in ... 10 years of experience with a strong background in manual ... the 10th PRN clinic in and around the Denver ...
(Date:8/7/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) today ... effective Aug. 7, 2017. ... interests and will serve as president emeritus during a planned, ... in multiple leadership roles since he joined Diplomat with the ... provided decisive, strategic leadership which continues to benefit our patients ...
(Date:8/3/2017)... 3, 2017  Opioid addiction and other drugs of ... costs and threatening outcomes, were problems taken on directly ... industry that support them, met this week. This according ... that drugs of abuse, procalcitonin and acute kidney injury ... organization,s 69th meeting in San Diego, CA. ...
Breaking Medicine Technology: